EPISODE · Jul 7, 2020 · 45 MIN
CBD In Treatment of Alzheimers, Addictions and Mood Disorders
from Counselor Toolbox Podcast with DocSnipes · host Dr. Dawn-Elise Snipes
Summary - CBD is showing promise as an alternative or adjunctive treatment for a variety of ailments ranging from Alzheimer’s and Addiction to Parkinson’s and Schizophrenia. - CBD does not have the psychogenic effects that THC does, however, THC has been found to be more effective at addressing some issues - OTC CBD is nonstandardized so dosages, even from the same manufacturer, but in different lots may have different potencies - CBD interacts with most medications, so it is vital to consult a physician prior to using it. - Dosages of CBD in the literature varied widely. - Currently there are a couple CBD based medications for the treatment of seizure disorder - CBD oils also may have a trace of THC in them—again, in OTC formulations, it may be variable, but supposed to be less than 0.3% Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Summary - CBD is showing promise as an alternative or adjunctive treatment for a variety of ailments ranging from Alzheimer’s and Addiction to Parkinson’s and Schizophrenia. - CBD does not have the psychogenic effects that THC does, however, THC has been found to be more effective at addressing some issues - OTC CBD is nonstandardized so dosages, even from the same manufacturer, but in different lots may have different potencies - CBD interacts with most medications, so it is vital to consult a physician prior to using it. - Dosages of CBD in the literature varied widely. - Currently there are a couple CBD based medications for the treatment of seizure disorder - CBD oils also may have a trace of THC in them—again, in OTC formulations, it may be variable, but supposed to be less than 0.3% Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
CBD In Treatment of Alzheimers, Addictions and Mood Disorders
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m